Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
How to Cite
OrthoEvidence. Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain. ACE Report. 2018;7(9):13. Available from: https://myorthoevidene.com/AceReport/Report/10350
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatmentEur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.x
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
303 patients with peripheral neuropathic pain (PNP) were randomized to either Nabiximols or placebo for 14 weeks. Significant improvements in pain, quality of sleep and Subject Global Impression of Change (SGIC) were found in patients that received Nabiximols compared to those that received placebo. No patients experienced severe treatment-related adverse events in the Sativex group versus one in ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE